Investor Relations

Company Description

News

Financial Reports

Financial Calendar

Presentations

The Share

New Issues

Corporate Governance

IR Contact

Dignitana signs master contract with American Oncology Network

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB, world leader in scalp cooling innovation, announced today that the Company has signed a master contract with American Oncology Network (AON), an alliance of community oncology practices in the United States. The FDA cleared DigniCap® Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.

The agreement provides the opportunity for any of the 45 AON locations to easily provide DigniCap Scalp Cooling for their patients. This week two AON practices have added DigniCap services under this new agreement.

AON is a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings. AON currently serves an expanding network of partner practices across 12 states, providing dedicated end-to-end administrative support, access to an extensive array of centralized ancillary services, and proven practice management expertise.

“This partnership with Dignitana enables us to improve the patient experience,” said AON CEO Brad Prechtl, MBA. “Our physicians are committed to providing exceptional cancer care. By being able to offer DigniCap to patients undergoing chemotherapy, we’ll be helping to diminish the added emotional burden from hair loss.”

“AON provides a unique model of physician-led community oncology that aligns well with our organizational goals,” said William Cronin, Chief Executive Officer of Dignitana AB.  “Physicians know that hair loss is a significant quality of life issue and they want to provide DigniCap for their patients. This master contract expedites the administrative process so that more patients can access this life-changing therapy.”

The DigniCap Scalp Cooling System is available at over 160 locations in 30 states in the U.S. and in 38 markets globally.

 

--------------------------

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 77 physicians and 46 nurse practitioners and physician assistants practicing across 12 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt
Director of Marketing
Caroline.Hewitt@AONcology.com
+1 239.789.2341

For More Information Contact

Dignitana Investor Relations +1 469 518 5031 investorrelations@dignitana.com

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se